Navigation Links
Curing coronavirus with curiosity
Date:9/12/2013

Cell biologist Carolyn Machamer, Ph.D is The Pew Charitable Trusts' biomedical researcher of the month for her creative work on coronaviruses. Specifically, Machamer studies how the family of viruses uses a host cell's machinery against it.

While most coronaviruses result only in the common cold, those responsible for Middle East respiratory syndrome (MERS) and SARS can lead to fatal pneumonia. Machamer researches how coronaviruses infect cells, focusing on how their viral proteins use the host cells' structures to assemble into infectious agents that are then released into the body. She believes that curiosity-driven research into the mechanisms of virus-host interactions will lead to treatments and vaccines for MERS, SARS, and a range of viruses that behave similarly.

Machamer's story is part of a biomedical researcher of the month series launched by Pew. Since 1985, Pew's biomedical programs have provided funding to more than 500 early-career investigators who, like Machamer, show outstanding promise in science with the potential to advance human health. The scholars' exceptional research has earned them Nobel Prizes, Lasker Awards, MacArthur Foundation "genius" grants and other distinctions.


'/>"/>

Contact: Chelsea Toledo
ctoledo@pewtrusts.org
202-540-6846
Pew Health Group
Source:Eurekalert

Page: 1

Related biology news :

1. Mass. Eye and Ear announces Curing Kids Fund grant recipients
2. Conference on securing the future supply of food: Challenges and opportunities
3. New coronavirus related to viruses from bats
4. New coronavirus has many potential hosts, could pass from animals to humans repeatedly
5. Novel coronavirus well-adapted to humans, susceptible to immunotherapy
6. Researchers describe potential for MERS coronavirus to spread internationally
7. Scientists engineer strain of MERS coronavirus for use in a vaccine
8. Chemistry on Mars video with Curiosity Rover from the American Chemical Society
9. Curiosity on Mars sits on rocks similar to those found in marshes in Mexico
10. Viral curiosity spreads across continents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... BARCELONA , Spanien, 27. Februar 2017 /PRNewswire/ ... durch Iris-Scan, wird seine erstklassige biometrische Lösung ... Snapdragon™ 835 mit X16 LTE auf dem ... 2. März) am Qualcomm-Stand in Halle 3, ... 835-Prozessor beinhaltet die Sicherheitsplattform Qualcomm Haven™ – ...
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)...  BioPharmX Corporation (NYSE MKT: BPMX), a specialty ... today reported financial results for the quarter and ... an update on the company,s clinical development efforts ... are pleased to report that last year was ... Anja Krammer. "We achieved key clinical milestones and ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/23/2017)... , March 23, 2017 ... at four equities in the Biotech industry: Sangamo Therapeutics ... Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. ... st , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology ... downloading their free report at: ...
Breaking Biology Technology: